Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Mesa Laboratories
MLAB
$564M
| $9.1M | ﹤0.01% |
33,573
+678
| +2% | +$172K |
|
|
SP
2052
DELISTED
SP Plus Corporation
SP
| $9.1M | ﹤0.01% |
297,519
+3,974
| +1% | +$130K |
|
|
XRN
2053
Chiron Real Estate Inc
XRN
$514M
| $9.09M | ﹤0.01% |
123,144
+25,823
| +27% | +$1.87M |
|
2054
New Fortress Energy
NFE
$92.1M
| $9.08M | ﹤0.01% |
239,687
+158,927
| +197% | +$6.8M |
|
2055
Marcus & Millichap
MMI
$1.16B
| $9.05M | ﹤0.01% |
232,780
+9,676
| +4% | +$363K |
|
2056
The RealReal
REAL
$1.46B
| $9.05M | ﹤0.01% |
457,838
+43,067
| +10% | +$880K |
|
2057
BioLife Solutions
BLFS
$1.53B
| $9.04M | ﹤0.01% |
203,178
+54,000
| +36% | +$1.9M |
|
2058
Agilon Health
AGL
$1.53B
| $9.02M | ﹤0.01% |
+8,896
| New | +$7.79M |
|
2059
Codexis
CDXS
$151M
| $9.02M | ﹤0.01% |
398,220
+11,488
| +3% | +$249K |
|
2060
Atara Biotherapeutics
ATRA
$75.5M
| $9.02M | ﹤0.01% |
23,204
+589
| +3% | +$210K |
|
|
EBIX
2061
DELISTED
Ebix Inc
EBIX
| $9.01M | ﹤0.01% |
265,895
+13,555
| +5% | +$420K |
|
|
EVOP
2062
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $9M | ﹤0.01% |
324,468
+8,024
| +3% | +$229K |
|
2063
MiMedx Group
MDXG
$602M
| $8.81M | ﹤0.01% |
704,206
+248,268
| +54% | +$2.69M |
|
|
OSG
2064
Octave Specialty Group
OSG
$243M
| $8.81M | ﹤0.01% |
562,349
+42,090
| +8% | +$676K |
|
2065
Astrana Health
ASTH
$1.76B
| $8.8M | ﹤0.01% |
140,138
+36,407
| +35% | +$1.35M |
|
2066
Douglas Dynamics
PLOW
$1.02B
| $8.78M | ﹤0.01% |
215,852
+8,542
| +4% | +$375K |
|
|
GTS
2067
DELISTED
Triple-S Management Corporation
GTS
| $8.77M | ﹤0.01% |
393,837
+20,608
| +6% | +$512K |
|
2068
Citi Trends
CTRN
$555M
| $8.74M | ﹤0.01% |
100,423
-16,570
| -14% | -$1.52M |
|
|
CONN
2069
DELISTED
Conn's Inc.
CONN
| $8.74M | ﹤0.01% |
342,597
-35,861
| -9% | -$828K |
|
|
APTS
2070
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $8.73M | ﹤0.01% |
895,196
+59,200
| +7% | +$600K |
|
|
HT
2071
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $8.69M | ﹤0.01% |
807,860
-32,563
| -4% | -$360K |
|
2072
Ennis
EBF
$552M
| $8.68M | ﹤0.01% |
403,471
+34,144
| +9% | +$721K |
|
2073
John B. Sanfilippo & Son
JBSS
$967M
| $8.68M | ﹤0.01% |
98,031
+6,980
| +8% | +$635K |
|
2074
LeMaitre Vascular
LMAT
$2.32B
| $8.66M | ﹤0.01% |
141,906
+27,912
| +24% | +$1.48M |
|
2075
FB Financial Corp
FBK
$3.02B
| $8.63M | ﹤0.01% |
231,122
+17,495
| +8% | +$726K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.